Early radiotherapy linked to better response after thyroidectomy
Research inClinical Endocrinology suggests that adults with differentiated thyroid cancer, who undergo thyroidectomy and start radioiodine therapy within the first three months after surgery, have better outcomes.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 19, 2018 Category: Endocrinology Source Type: news

Radioiodine Therapy for Thyroid Cancer Doesn ’ t Up Stroke Risk
I - 131 therapy group showed no significantly higher risk of ischemic or hemorrhagic stroke (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 19, 2017 Category: Cancer & Oncology Tags: Cardiology, Endocrinology, Family Medicine, Internal Medicine, Neurology, Oncology, ENT, Radiology, Journal, Source Type: news

Surgically Ablated Thyroid Cancer Does Not Need Adjuvant RAISurgically Ablated Thyroid Cancer Does Not Need Adjuvant RAI
In patients with intermediate-risk thyroid cancer that has been surgically ablated, adjuvant radioiodine therapy may not be necessary. Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 12, 2016 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

miR-339-5p modulates NIS-mediated RAIU
Na+/I− symporter (NIS)-mediated radioiodide uptake (RAIU) serves as the basis for targeted ablation of thyroid cancer remnants. However, many thyroid cancer patients have reduced NIS expression/function. microRNAs (miRs) have emerged as a promising therapeutic method; Lakshmanan and colleagues make the first report to demonstrate that hNIS-mediated RAIU can be modulated by miRs, and that the same miRs may also play roles in thyroid malignancy. Accordingly, miRs may serve to halt the progression of thyroid cancer and to enhance the efficacy of radioiodine therapy. Read the full article at Lakshmanan et al. (2015)...
Source: Society for Endocrinology - January 26, 2015 Category: Endocrinology Source Type: news

New guidance on radioiodine therapy use after radiographic studies
Researchers have provided new evidence that could act as a guide for the use of radioiodine therapy after patients have undergone radiographic imaging studies that use iodine as a contrasting agent. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 1, 2013 Category: Cancer & Oncology Source Type: news